Company · CIK 0001580063
BIORA THERAPEUTICS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001213900-24-113256 · 542.0 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-134755 · 168.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-24-127060 · 11.2 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-127030 · 463.7 KBSEC(opens sec.gov)
- SC 13GBIORA THERAPEUTICS, INC.0000902664-24-006541 · 52.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-246602 · 572.0 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-114214 · 218.9 KBSEC(opens sec.gov)
- SC 13D/ABIORA THERAPEUTICS, INC.0001193125-24-235295 · 254.5 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-113271 · 186.9 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-24-106347 · 186.3 KBSEC(opens sec.gov)
Insiders
- Alter Jeffrey D.Director
- Athyrium Capital Management, LP10% Owner
- Athyrium Opportunities Fund (A) LP10% Owner
- Athyrium Opportunities Fund (B) LP10% Owner
- Athyrium Opportunities III Co-Invest 1 LPDirector, 10% Owner
- Bigalke John T.Director
- Cooper Matthew TGeneral Manager, Diagnostics
- dEsparbes EricChief Financial Officer
- Ferrell JeffreyDirector, 10% Owner
- Gianakopoulos GeorgeSenior Vice President of Sales
Tickers
No tickers on record.
Addresses
business
4330 LA JOLLA VILLAGE DRIVE SUITE 200
SAN DIEGO, CA, 92122
mailing
4330 LA JOLLA VILLAGE DRIVE SUITE 200
SAN DIEGO, CA, 92122
Former names
- PROGENITY, INC.2022-04-19
- ASCENDANT MDX, INC.2013-06-28
Same industry